Atorvastatin for patients with cirrhosis. A randomized, placebo-controlled trial

BACKGROUND: Patients with cirrhosis and portal hypertension face a high risk of complications. Besides their anti-inflammatory and antifibrotic effects, statins may reduce portal pressure and thus the risk of complications and mortality. We aimed to investigate the effects of atorvastatin on hospita...

Descripción completa

Detalles Bibliográficos
Autores principales: Kronborg, Thit M., Schierwagen, Robert, Trošt, Kajetan, Gao, Qian, Moritz, Thomas, Bendtsen, Flemming, Gantzel, Rasmus H., Andersen, Mette L., Teisner, Ane S., Grønbæk, Henning, Hobolth, Lise, Møller, Søren, Trebicka, Jonel, Kimer, Nina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10697620/
http://dx.doi.org/10.1097/HC9.0000000000000332

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10697620/
http://dx.doi.org/10.1097/HC9.0000000000000332

Ejemplares similares